GW274150
CAS No. 210354-22-6
GW274150 ( GW-274150 | GW 274150 )
产品货号. M13344 CAS No. 210354-22-6
GW274150 是一种有效且高度选择性的 iNOS 抑制剂,IC50 为 1.4 uM,
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ¥708 | 有现货 |
|
| 10MG | ¥1169 | 有现货 |
|
| 25MG | ¥2390 | 有现货 |
|
| 50MG | ¥3841 | 有现货 |
|
| 100MG | ¥5292 | 有现货 |
|
| 200MG | ¥7155 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称GW274150
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述GW274150 是一种有效且高度选择性的 iNOS 抑制剂,IC50 为 1.4 uM,
-
产品描述GW274150 is a potent and highly selective inhibitor of iNOS with IC50 of 1.4 uM, displays >200 fold selectivity over eNOS and nNOS (IC50>100 uM); attenuates the degree of chronic inflammation and tissue damage associated with collagen-induced arthritis in mice; significantly reduces serum urea, serum creatinine, AST, and NAG, reduces experimental renal ischemia/reperfusion injury.Rheumatoid Arthritis Phase 2 Discontinued.
-
体外实验GW274150 inhibits intracellular iNOS in J774 cells in a time-dependent manner, reaching IC50?values of 0.2 μM.GW274150?is >260-fold and 219-fold selective for iNOS against eNOS and nNOS in rat tissues, respectively. And it displays >100-fold and >80-fold for human iNOS against human eNOS and nNOS, respectively.
-
体内实验GW274150 is a long-acting (5 h half‐life in rats) iNOS inhibitor and is able to inhibit LPS‐mediated increase in plasma NO2-,?NO3-?levels 14 h after single intraperitoneal dose (ED50=3 mg/kg).GW274150 (intraperitoneal?injection; 2.5, 5, and 10 mg/kg; before carrageenan injection) reduces the degree of lung injury induced by carrageenan in a dose-related fashion. Oedema formation and PMNs infiltration in the pleural cavity are also significantly attenuated in a dose‐related manner in rats.GW274150 (oral adminstration; 30 mg/kg; twice daily; 7 days) leads to significant neuroprotection, However, it displays a bell-shaped neuroprotective profile, being ineffective at high doses in 6-OHDA rat model of Parkinson disease (PD). Animal Model:SD-rat Dosage:2.5, 5 and 10 mg/kg; single dose Administration:Intraperitoneal?injection 5 min before carrageenan injection Result:Exerted a protective role in an acute model of inflammation, carrageenan-induced lung injury.
-
同义词GW-274150 | GW 274150
-
通路Immunology/Inflammation
-
靶点NOS
-
受体NOS
-
研究领域Inflammation/Immunology
-
适应症Rheumatoid Arthritis
化学信息
-
CAS Number210354-22-6
-
分子量219.3045
-
分子式C8H17N3O2S
-
纯度>98% (HPLC)
-
溶解度H2O: ≥ 62 mg/mL
-
SMILESCC(=N)NCCSCC[C@@H](C(=O)O)N
-
化学全称L-Homocysteine, S-[2-[(1-iminoethyl)amino]ethyl]-
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Young RJ, et al. Bioorg Med Chem Lett. 2000 Mar 20;10(6):597-600.
2. Cuzzocrea S, et al. Eur J Pharmacol. 2002 Oct 18;453(1):119-29.
3. McDonald MC, et al. J Physiol Pharmacol. 2002 Dec;53(4 Pt 1):555-69.
4. Chatterjee PK, et al. Kidney Int. 2003 Mar;63(3):853-65.
产品手册
关联产品
-
BYK191023 dihydrochl...
BYK191023 diHClide (BYK-191023) 是一种有效的、高选择性的诱导型一氧化氮合酶 (iNOS) 抑制剂,IC50 为 86 nM。
-
TP508
TP508 is a 23 amino acid synthetic peptide representing residues 508-530 of human prothrombin which is identified as a potential receptor-binding domain based on competition for high-affinity thrombin binding to fibroblasts.TP508 (Chrysalin) is an investigational peptide drug that was developed for use in stimulating repair of dermal and musculoskeletal tissues.
-
Tsugaric acid A
津甘酸 A 能显着抑制 fMLP/CB 刺激的大鼠中性粒细胞中超氧阴离子的形成,还能够保护人角质形成细胞免受紫外线 B (UV B) 光诱导的损伤,表明津甘酸 A 可以保护角质形成细胞免受光损伤。
021-51111890
购物车()
sales@molnova.cn

